Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Rang in Aktien #38667
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Aktienkurs
$0.04057595
Zuletzt synchronisiert: 2024-08-05
Marktkapitalisierung
$863.62K
Veränderung (1 Tag)
0.31%
Veränderung (1 Jahr)
0.00%
Land
SE
Handel AegirBio AB (publ) (AEGIR)

Kategorie

Kursverlauf für AegirBio AB (publ) (AEGIR)
Höchster Schlusskurs: $0.04 am 2024-08-01

Niedrigster Schlusskurs: $1.13 am 2020-06-01
Kursverlauf der Aktie von AegirBio AB (publ) von 2020 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2024 -58.92%
2023 -75.96%
2022 -92.79%
2021 111.22%
2020 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$399.20 -16.32%
US
$192.81 -37.10%
FR
$173.84 33.48%
JP
$183.25 19.54%
US
$78.92 -8.22%
CH